戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              Lambert Eaton myasthenic syndrome and acquired neuromyot
2                                              Lambert et al question our retrospective and holistic ep
3                                              Lambert et al. make clever use of psoriasis patient gene
4                                              Lambert et al. reported that silicate ions catalyze the
5                                              Lambert-Eaton myasthenic syndrome (LEMS) is a paraneopla
6                                              Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmun
7                                              Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmun
8                                              Lambert-Eaton myasthenic syndrome IgG did not selectivel
9 mplitudes were correlated with decibel and 1/Lambert DLS for the central 18 degrees of the visual fie
10 ensitivities (both in logarithmic [dB] and 1/Lambert scales [1/L]), were investigated with components
11     There was a linear correlation between 1/Lambert DLS and PERG amplitude (transient PERG: R(2) = 0
12 im area, and a linear relationship between 1/Lambert DLS and PERG amplitude and neuroretinal rim area
13     There was a linear correlation between 1/Lambert DLS and temporal neuroretinal rim area (R(2) = 0
14 .75%, and -0.78% per year for decibel DLS, 1/Lambert DLS, transient PERG, and SS PERG, respectively.
15                     The decibel is 10. log(1/Lambert), where the Lambert is the unit of test spot int
16            The RS values were converted to 1/Lambert.
17  limbic encephalitis, 3 cerebellar ataxia, 2 Lambert-Eaton myasthenic syndrome, 1 autonomic neuropath
18              The method was implemented in a Lambert-Beer linear concentration range to facilitate tr
19 ataxia type 2, spinocerebellar ataxia 6, and Lambert-Eaton myasthenic syndrome), and the skeletal mus
20 ption of the opsoclonus-myoclonus ataxia and Lambert-Eaton myasthenic syndromes.
21 nase antibody-positive myasthenia gravis and Lambert-Eaton myasthenic syndrome are about 20 times les
22                        Myasthenia gravis and Lambert-Eaton myasthenic syndrome are antibody-mediated
23  predict the course of myasthenia gravis and Lambert-Eaton myasthenic syndrome are needed.
24 ome, dermatomyositis, myasthenia gravis, and Lambert-Eaton myasthenic syndrome.
25                   Myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) are autoimmune
26 ia gravis can be associated with thymoma and Lambert-Eaton myasthenic syndrome with small-cell lung c
27 he toxicity-normalized SSD (SSDn) approach, (Lambert, F.
28                       Some syndromes such as Lambert-Eaton myasthenic syndrome and neuromyotonia are
29 t underlie muscle weakness in the autoimmune Lambert-Eaton myasthenic syndrome (LEMS).
30 tonomic symptoms characterize the autoimmune Lambert-Eaton myasthenic syndrome (LEMS).
31                                Applying Beer-Lambert's Law eliminated the effect of sample thickness
32  microscopic optical path lengths, both Beer-Lambert's law and the law of superposition were found to
33 e obtained, quantitatively obeying both Beer-Lambert's law and the law of superposition, despite the
34    Quantitative analysis is governed by Beer-Lambert Law relationships.
35 on in the ITO, causing a deviation from Beer-Lambert absorption that results in an optimum ITO thickn
36 ted with wavelength-dependent, modified Beer-Lambert Law.
37                Differences in the Ir/Ni Beer-Lambert absorption profiles allow the rate to be increas
38 on plots are assessed in the context of Beer-Lambert's law and provide combined with time-dependent d
39  optically thick conditions, given that Beer-Lambert's law is valid.
40                  The algorithm uses the Beer-Lambert equation in the framework of X-ray transmission
41 so establishes that deviations from the Beer-Lambert law can be expected when (a) the light source is
42 in coincide with those predicted by the Beer-Lambert law for a range of ferricyanide concentrations f
43                                     The Beer-Lambert law is obeyed by both porphyrin forms.
44 xperimentally, that deviations from the Beer-Lambert law of up to +/-10% occur.
45  related to platinum concentration (the Beer-Lambert Law).
46 oncentration (in contradiction with the Beer-Lambert law).
47 ration of analytes-as postulated by the Beer-Lambert law-is one of the fundamental assumptions that m
48 ography (SXCMT) and an extension of the Beer-Lambert law.
49  coefficient (epsilon) and applying the Beer-Lambert law.
50 e observed absorbances deviate from the Beer-Lambert law.
51  using the spectroscopic method and the Beer-Lambert law.
52 sing from either the energy loss of the Beer-Lambert-Bouguer transmission law or the evanescent penet
53 tain ataxia symptoms such as those caused by Lambert-Eaton disease.
54 eatment for neuromuscular weakness caused by Lambert-Eaton myasthenic syndrome.
55 systemic therapies.See related commentary by Lambert and Jones, p.
56 s developed electrophysiologically confirmed Lambert-Eaton myasthenic syndrome.
57 ved in the autoimmune neuromuscular disorder Lambert-Eaton myasthenic syndrome.
58 e characteristic of the autoimmune disorder, Lambert-Eaton syndrome (LES).
59 ved in an autoimmune neuromuscular disorder, Lambert-Eaton myasthenic syndrome.
60 equency relation is established by employing Lambert's special function or alternatively using linear
61 uropathy, movement disorder, encephalopathy, Lambert-Eaton syndrome, and seizures.
62                To evaluate the Dutch-English Lambert-Eaton Myasthenic Syndrome (LEMS) Tumour Associat
63 o coimmunogenic tumor antigens, for example, Lambert-Eaton syndrome (P/Q-type Ca(2+) channel antibody
64 d JMG, 141 (38.7%) had CMS, and 6 (1.7%) had Lambert-Eaton syndrome, diagnosed at a median age of 13.
65 ation patients without clinically identified Lambert-Eaton myasthenic syndrome had P/Q-type voltage-g
66 lastic cerebellar degeneration, but improved Lambert-Eaton myasthenic syndrome symptoms.
67                                           In Lambert-Eaton myasthenic syndrome (LEMS), SOX antibodies
68 iated with small-cell lung cancer, including Lambert-Eaton myasthenic syndrome (LEMS) and paraneoplas
69                                    Swiss Jim Lambert (SJL) and Friend Virus B (FVB) mice progressivel
70 ciated with Waldenstrom's macroglobulinemia, Lambert-Eaton myasthenic syndrome, and multifocal motor
71 d/or signs were present in 18 of 23 (78%) of Lambert-Eaton myasthenic syndrome (LEMS) patients evalua
72 ations, although 1 developed a fatal case of Lambert Eaton myasthenic syndrome following ICI treatmen
73 d GV-58 in a passive transfer mouse model of Lambert-Eaton myasthenic syndrome and have shown that we
74 euromuscular diseases myasthenic syndrome of Lambert-Eaton and botulism.
75 t, some PNSs such as sensory neuronopathy or Lambert-Eaton myasthenic syndrome rarely occur in lympho
76 c neuromuscular junction disorder resembling Lambert-Eaton myasthenic syndrome.
77 syn I, DeMarini DM, Caldwell JC, Kavlock RJ, Lambert P, Hecht SS, Bucher JR, Stewart BW, Baan R, Cogl
78          Previous work has demonstrated that Lambert-Eaton syndrome (LES) antibodies reduce calcium c
79                                          The Lambert-Beer's law was obeyed in the range of 0.07-3.0 m
80  diseases, such as diabetes mellitus and the Lambert-Eaton myasthenic syndrome.
81                  Some disorders, such as the Lambert-Eaton myasthenic syndrome, are effectively treat
82 and demonstrated an autoimmune basis for the Lambert Eaton myasthenic syndrome and 'seronegative' mya
83 ubtype that is targeted by antibodies in the Lambert-Eaton myasthenic syndrome has been identified, a
84 The decibel is 10. log(1/Lambert), where the Lambert is the unit of test spot intensity.
85 ced improvement in several patients with the Lambert-Eaton myasthenic syndrome and myasthenia gravis
86 ion sometimes occurs in association with the Lambert-Eaton myasthenic syndrome.
87 There was one treatment-related death due to Lambert-Eaton syndrome in a PD-L1-negative patient durin
88                                        Using Lambert salt-initiated hydroarylation of isatin, a diver
89 a were recorded and epsilon calculated using Lambert-Beer's law.
90 ls of gabapentin funded by Pfizer and Warner-Lambert's subsidiary, Parke-Davis (hereafter referred to
91 thenic syndrome and have shown that weakened Lambert-Eaton myasthenic syndrome-model neuromuscular sy
92 ample, P/Q-type Ca(2+)-channel antibody with Lambert-Eaton syndrome (n = 5), anti-neuronal nuclear an
93                     Incubation of cells with Lambert-Eaton myasthenic syndrome IgG for 24 to 48 hours